Idaho Statutes

Idaho Statutes are updated to the web July 1 following the legislative session.


54-1733F.  tuberculin purified protein derivative products — screening. Notwithstanding any other provision of law, a pharmacist acting in good faith and exercising reasonable care may prescribe and administer a tuberculin purified protein derivative product approved by the federal food and drug administration to a patient for the purpose of screening for tuberculosis infection, provided the following conditions are met:
(1)  Prior to prescribing and administering a tuberculin purified protein derivative product, the pharmacist must successfully complete a course on proper test administration and interpretation of results from the United States centers for disease control and prevention (CDC) or a comparable course from a provider accredited by the accreditation council for pharmacy education;
(2)  The pharmacist shall follow the recommendations for Mantoux tuberculin skin testing from the CDC regarding test administration and interpretation of results;
(3)  Documentation of test results shall be maintained in the records of the pharmacy and a copy of the results shall be made available to the patient upon request; and
(4)  If the patient is found to have a positive test reading:
(a)  The pharmacist shall coordinate a timely referral to the patient’s primary care provider, if applicable, or to a local clinic to coordinate further diagnostics and follow-up care; and
(b)  A report shall be submitted to the patient’s local health district or to the Idaho department of health and welfare in accordance with the rules governing Idaho reportable diseases.

[(54-1733F) 54-1733E, added 2017, ch. 23, sec. 2, p. 43; am. and redesig. 2018, ch. 169, sec. 19, p. 369.]

How current is this law?

Search the Idaho Statutes and Constitution